This information was published on 2022-06-15T06:44:58 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2226532 |
| (220) |
09 Nov 2021
|
| (300) |
US, 22 Oct 2021, 97087685
US, 27 Jul 2021, 90851335 |
| (511) (510) |
Class 42
Conducting clinical trials in the fields of pharmaceuticals and biotechnology including, conducting clinical trials for the for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticals and biotechnology; medical and scientific research, namely, conducting clinical trials for oligonucleotide-based therapeutics |
| (540) | MARINA |
| (550) | Word |
| (730) |
Avidity Biosciences Inc.
|
| (750) |
Davies Collison Cave Pty Ltd
|
Find out more about publications on the About page.